On #ClinicalTrialsDay, our colleagues Kimberley and Robina highlight the importance of bringing the voices of patients, caregivers and trial site staff into clinical research. Together we are championing the wellbeing of patients to create a healthier, inclusive and equitable tomorrow. Learn more about our commitment to clinical trials: https://lnkd.in/etWfE_r7 #LifeForward
Boehringer Ingelheim
Pharmaceutical Manufacturing
Ingelheim am Rhein, Rhineland-Palatinate 1,783,042 followers
About us
Our people are our strength. And, together with over 56,000 colleagues, we're creating the next breakthrough in the world of health and innovation for both humans and animals. Are you ready to join us? #LifeForward
- Website
-
http://www.boehringer-ingelheim.com
External link for Boehringer Ingelheim
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- Ingelheim am Rhein, Rhineland-Palatinate
- Type
- Privately Held
- Specialties
- Pharmaceuticals, Animal Health, Innovation, Research, Health Care, Improve Health, Biopharmaceuticals, and Contract Manufacturing
Locations
Employees at Boehringer Ingelheim
-
Gwen Whitfield Foster
-
Thomas Macauley
Research Data Management - Lab Services Engineer at Boehringer-Ingelheim
-
Mitchell Taub
Highly Distinguished Research Fellow
-
Ralf Schundelmeier
Product Leader (ex Salesforce) - Building Platforms and Applications for Analytics, AI / Machine Learning & Data
Updates
-
“Never assume, always ask.” Building long-term, trusted partnerships with communities at risk of being underrepresented in clinical trials is essential to understand their barriers of participation and co-create solutions addressing their needs. Together we can build a healthier, inclusive and equitable tomorrow. Learn more about our commitment to clinical trials: https://lnkd.in/gB7Jg2Rf #ClinicalTrialsDay #CTD2024 #ClinicalTrials
-
We couldn’t agree more with this statement. We need to work together to optimize care pathways for people living with schizophrenia. That’s why we support the European Brain Council with ‘ ‘Rethinking Schizophrenia: Beyond the Voices’. The report sets out a clear direction for policymakers to improve schizophrenia care. Find out more: https://lnkd.in/exzWwaJj
"All schizophrenia patients deserve stigma-free lives regardless of their social status. EU representatives must unite for accessible and science-based care. We can beat schizophrenia together." - MEP Tomáš Zdechovský We call on EU and national policymakers and decision-makers across Europe to improve the lives of people living with schizophrenia through the optimisation of their care pathway. Investments in schizophrenia research and innovation are needed to better understand the pathophysiology, mechanisms, and risk factors of schizophrenia. 🔗 Learn more about the Rethinking Schizophrenia project & the report: https://lnkd.in/dNYmU-MU #RethinkingSchizophrenia #BeyondTheVoices
-
In our clinical trials, patient centricity and site centricity go hand-in-hand. This means we partner with patients, caregivers and trial site staff to design and conduct our clinical trials. Trial site staff bring important insights and experiences to the table, and they are the ones delivering the patient experience in clinical trials. Together, we can make patient-centric trials possible, and, ultimately, deliver new medicines to patients faster. Learn more about our commitment to clinical trials: https://lnkd.in/etWfE_r7 #ClinicalTrialsDay #CTD2024
-
Did you know that 20 million people die from cardio-renal-metabolic (CRM) diseases every year? Although these diseases affecting organs such as the heart, kidneys and liver can be connected, they're often treated separately. That's why we develop treatments that consider the whole patient, and the way the body’s systems interact. Take a look ➡️ https://bit.ly/4dhAGiI #AnnualReport #CardioRenalMetabolic
-
#PRESS: We have just launched BULTAVO 3™, a new vaccine that protects sheep and cattle against #bluetongue virus serotype 3 (BTV-3). Bluetongue is a transboundary animal disease affecting ruminants, posing a threat to animals, farmers, and public health. BULTAVO 3™ is the first BTV-3 vaccine that prevents both clinical signs of the disease and mortality. Following recent outbreaks in Europe, it is currently licensed for use in the Netherlands. Learn more about our latest vaccine innovation and how it limits the impact of bluetongue: https://lnkd.in/eDV4Bg-c
-
#HCP: Dr. Susanne Nicholas discusses the importance of kidney health, and why early and regular testing is key to preventing the progression of #ChronicKidneyDisease (CKD). When testing for CKD, It Takes 2 tests – an eGFR (blood) and UACR (urine) test – to get the full picture. Watch to learn more!
-
Curious to learn how #AI can detect cough in pigs five days earlier than conventional detection methods without a farmer or veterinarian setting a foot in a barn? Then read on and test your ability to identify the severity of respiratory issues in pigs – can you beat AI? 💪 https://bit.ly/3UzylbP #AnnualReport #AnimalHealth
-
Having healthy vision is something taken for granted by many. Did you know that diabetes is the leading cause of blindness? Take a look at what we do in our in-house research in diabetic eye diseases as well as through partnerships with biotechs, academic institutions, and advocacy organizations to develop breakthrough treatments and foster awareness. ➡️ https://bit.ly/49SRR7E #AnnualReport #RetinalHealth
-
Transboundary animal diseases such as bluetongue, foot-and-mouth disease and avian influenza spread fast, quickly impacting #AnimalHealth, #livestock trade and even food security. They can cause massive global disruptions – but our technology is ready to fight them. 👉 https://lnkd.in/eAttPbDc